A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer.
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2013
At a glance
- Drugs Anastrozole (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 29 Jan 2013 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
- 20 Jan 2011 Actual initiation date changed from Aug 2004 to Jun 2005 as reported by ClinicalTrials.gov.
- 26 Oct 2007 New trial record.